Literature DB >> 8709638

Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone.

F Alfinito1, L Del Vecchio, S Rocco, P Boccuni, P Musto, B Rotoli.   

Abstract

The membrane expression of nine glycosyl phosphatidyl inositol (GPI)-linked molecules was analyzed by flow cytometry on circulating cells from 18 patients affected by paroxysmal nocturnal hemoglobinuria (PNH). The results allowed us to select CD66b, CD14, CD59, CD24 and CD59 monoclonal antibodies as the most suitable reagents for discriminating between normal and PNH cells in PMN, monocytes, RBC and B or T lymphocytes, respectively. In order to assess whether the analysis of distinct cell populations could provide differential information on the extent of the disease, we compared the proportion of residual normal cells in RBC, monocyte and PMN populations. The mean percentage of unaffected cells was higher in RBC as compared to PMN (50.5 +/- 18.7 vs 17.7 +/- 19.7, P < 0.0001). The proportion of normal PMN was, in turn, significantly greater than that of normal monocytes (17.7 +/- 19.7 vs 8.7 +/- 11.0; P < 0.05). The percentage of CD14+ monocytes was directly related to Hb concentration and platelet (Plt) count, and inversely to percent lysis at the Ham's test. The percentage of CD66b+ PMN was directly related to Plt count and Hb level, while the percentage of CD59+ RBC was associated, in an inverse fashion, only to the Ham's test. No significant correlation was found between cell marker expression and PMN count, reticulocytosis, bilirubin and serum LDH. By dividing the patients into two groups, according to high (> 10 percent) or low (< 10 percent) percentage of CD14+ monocytes, a statistical analysis showed that the main hematological parameters were significantly different.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709638

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  10 in total

1.  Paroxysmal nocturnal hemoglobinuria and eculizumab.

Authors:  Lucio Luzzatto; Antonio Maria Risitano; Rosario Notaro
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

2.  Budd-Chiari syndrome in a paroxysmal nocturnal hemoglobinuria patient with previous cerebral venous thrombosis.

Authors:  Antonella Tufano; Nicola Macarone Palmieri; Ernesto Cimino; Fiorella Alfinito; Anna Maria Cerbone
Journal:  Intern Emerg Med       Date:  2008-08-02       Impact factor: 3.397

Review 3.  Multidisciplinary clinical management of paroxysmal nocturnal hemoglobinuria.

Authors:  Fahri Sahin; Melda Comert Ozkan; Nihal Gokmen Mete; Mumtaz Yilmaz; Nevin Oruc; Alev Gurgun; Meral Kayikcioglu; Ayse Guler; Figen Gokcay; Ferda Bilgir; Cengiz Ceylan; Oktay Bilgir; Ismail Hakan Sari; Guray Saydam
Journal:  Am J Blood Res       Date:  2015-06-15

4.  Mutation analysis of the PIG-A gene in Korean patients with paroxysmal nocturnal haemoglobinuria.

Authors:  J H Yoon; H I Cho; S S Park; Y H Chang; B K Kim
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

Review 5.  Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria.

Authors:  Lucio Luzzatto; Giacomo Gianfaldoni
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

6.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06

7.  Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria.

Authors:  Jörg Schubert; Peter Hillmen; Alexander Röth; Neal S Young; Modupe O Elebute; Jeffrey Szer; Giacomo Gianfaldoni; Gérard Socié; Paul Browne; Robert Geller; Russell P Rother; Petra Muus
Journal:  Br J Haematol       Date:  2008-05-22       Impact factor: 6.998

8.  Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.

Authors:  Sa A Wang; Olga Pozdnyakova; Jeffrey L Jorgensen; L Jeffrey Medeiros; Dariusz Stachurski; Mary Anderson; Azra Raza; Bruce A Woda
Journal:  Haematologica       Date:  2008-11-10       Impact factor: 9.941

9.  Topological Structures and Membrane Nanostructures of Erythrocytes after Splenectomy in Hereditary Spherocytosis Patients via Atomic Force Microscopy.

Authors:  Ying Li; Liyuan Lu; Juan Li
Journal:  Cell Biochem Biophys       Date:  2016-08-24       Impact factor: 2.194

Review 10.  Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry.

Authors:  Margarida Lima
Journal:  Pract Lab Med       Date:  2020-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.